window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : November 1, 2025

  • News
  • About Us
Contact Us

atopic dermatitis

  • Events and Conferences,Patient Centricity,Pharmaceuticals and therapeutics,Real world evidence,Research & Development

    EADV 2025: Almirall showcases real-world evidence and pipeline progress in dermatology

    Almirall, a global biopharmaceutical company focused on medical dermatology, has [...]

    September 22, 2025
  • Biologics & Biosimilars,CDMOs & Manufacturing,Chronic diseases,Drug Development,Partnerships & Funding

    KBI Biopharma and Infinimmune partner on antibody manufacturing for atopic dermatitis programme

    KBI Biopharma has entered a collaboration with Infinimmune to support [...]

    September 17, 2025
  • Biologics & Biosimilars,Clinical Development,Drug Delivery & Formulation,Drug Development,Precision medicine

    Revolo moves oral formulation of allergy drug into development following preclinical boost

    Revolo Biotherapeutics says it is accelerating plans to bring a [...]

    August 6, 2025
  • Biologics & Biosimilars,Clinical Development,Drug Development,Rare Diseases,Regulatory Affairs

    FDA grants fast track to Nektar’s rezpegaldesleukin for severe alopecia areata

    Nektar Therapeutics has received FDA Fast Track designation for its [...]

    July 29, 2025
  • Clinical Development,Clinical Trials,Patient Centricity

    Phesi CEO warns of looming Phase 3 trial failures as sponsors overlook real-world data and overcrowd sites

    New analysis reveals billions risked on overly complex trials that [...]

    July 10, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2025 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Thermo Fisher Scientific accelerates biologic therapeutics development with new CHO K-1 cell line
    Categories: Biologics & Biosimilars, CDMOs & Manufacturing, Cell & Gene Therapy
  • FairJourney Biologics appoints Werner Lanthaler as chief executive officer
    Categories: Biologics & Biosimilars, Biotech, Movers & Shakers
  • Digital therapeutic cuts schizophrenia’s negative symptoms in trial
    Categories: Clinical Trials, Digital Health, Mental health, Neurosciences
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top